-
41
-
42
-
43
-
44
-
45
-
46
Causal relationship between educational attainment and the occurrence of venous thromboembolism
Published 2025-02-01“…Results Genetically predicted decreased EA was associated with a decreased risk of VTE in both the FinnGen consortium and UK Biobank (FinnGen-VTE: OR = 0.848; 95% CI 0.776—0.927; P = 2.84 × 10–4; UKB-VTE OR = 0.996; 95% CI 0.994—0.999; P = 0.008) under a multiplicative random-effects IVW model. …”
Get full text
Article -
47
Exploring the Causal Relationship Between Frailty and Chronic Obstructive Pulmonary Disease: Insights From Bidirectional Mendelian Randomization and Mediation Analysis
Published 2025-01-01“…The primary analytic approach was inverse variance weighted (IVW).Results: LDSC analysis revealed moderate genetic correlations between frailty and Global Biobank Meta-Analysis Initiative (GBMI) COPD (rg = 0.643, P = 6.66× 10− 62) as well as FinnGen COPD (rg = 0.457, P = 8.20× 10− 28). IVW analysis demonstrated that frailty was associated with increased risk of COPD in both the GBMI cohort (95% CI, 1.475 to 2.158; P = 2.40× 10− 9) and the FinnGen database (1.411 to 2.434; 9.02× 10− 6). …”
Get full text
Article -
48
-
49
-
50
-
51
-
52
-
53
La Chanson de la croisade albigeoise comme forge d’une histoire mythique
Published 2017-04-01Get full text
Article -
54
-
55
-
56
-
57
2. del: Kliniske fænomener af umiddelbar kriminogen betydning
Published 1967-03-01Get full text
Article -
58
-
59
Transatlantic Refractions: Ambivalence and Cultural Hybridity in the Euro-American Road Movie
Published 2010-11-01“…This article analyses a variety of ways in which the “road movie” has been reinterpreted by modern European directors (German Wim Wenders, Finn Aki Kaurismäki) or American director Jim Jarmusch with his pronounced European sensibilities. …”
Get full text
Article -
60
Tolerability and Effectiveness of Regorafenib Treatment in Patients with Unresectable Hepatocellular Carcinoma: Real-World Data from the United States
Published 2025-02-01“…Richard S Finn,1 Renuka Iyer,2 Richard S Kalman,3 Neehar D Parikh,4 Roniel Cabrera,5 Svetlana Babajanyan,6 Ahmed O Kaseb7 1Department of Medicine, University of California, Los Angeles, CA, USA; 2Department of Medicine, Roswell Park Cancer Institute, Buffalo, NY, USA; 3Department of Medicine, Einstein Medical Center, Philadelphia, PA, USA; 4Division of Gastroenterology and Hepatology, University of Michigan, Ann Arbor, MI, USA; 5Department of Medicine, University of Florida Health, Gainesville, FL, USA; 6US Medical Affairs, Oncology, Bayer Healthcare, Whippany, NJ, USA; 7Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USACorrespondence: Richard S Finn, Department of Medicine, University of California, Los Angeles, CA, USA, Tel +1-310-586-2091, Email rfinn@mednet.ucla.eduIntroduction: While several systemic therapies are available for unresectable hepatocellular carcinoma (uHCC), there is a lack of granular real-world evidence to support the efficacy and safety of these therapies. …”
Get full text
Article